REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $756,000 | -9.2% | 7,758 | +45.4% | 0.53% | -11.9% |
| Q2 2020 | $833,000 | +4.3% | 5,336 | -3.6% | 0.60% | -14.7% |
| Q1 2020 | $799,000 | +0.6% | 5,538 | +42.6% | 0.71% | +0.7% |
| Q4 2019 | $794,000 | +113.4% | 3,884 | -16.3% | 0.70% | +91.8% |
| Q3 2019 | $372,000 | -45.2% | 4,642 | -35.5% | 0.37% | -40.8% |
| Q2 2019 | $679,000 | -19.5% | 7,196 | -27.1% | 0.62% | -30.2% |
| Q1 2019 | $844,000 | +9.2% | 9,871 | -28.4% | 0.89% | +8.4% |
| Q4 2018 | $773,000 | – | 13,786 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |